These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16360065)

  • 1. Cost effectiveness of cardiac resynchronization therapy.
    Hlatky MA
    J Am Coll Cardiol; 2005 Dec; 46(12):2322-4. PubMed ID: 16360065
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of cardiac resynchronization therapy.
    Ward A; Guo S; Caro JJ
    J Am Coll Cardiol; 2006 Sep; 48(6):1283. PubMed ID: 16979020
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac resynchronization therapy: current state of the art: cost versus benefit.
    Auricchio A; Abraham WT
    Circulation; 2004 Jan; 109(3):300-7. PubMed ID: 14744954
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial.
    Owen A
    Eur Heart J; 2006 May; 27(9):1125; author reply 1125-6. PubMed ID: 16497689
    [No Abstract]   [Full Text] [Related]  

  • 5. Ventricular resynchronization: current state of the art.
    Leclercq C; Hare JM
    Circulation; 2004 Jan; 109(3):296-9. PubMed ID: 14744953
    [No Abstract]   [Full Text] [Related]  

  • 6. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
    Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiac resynchronization therapy: when the pacing site really matters].
    García-Bolao I
    Rev Esp Cardiol; 2007 Feb; 60(2):97-100. PubMed ID: 17338873
    [No Abstract]   [Full Text] [Related]  

  • 8. Questions in cardiac resynchronization therapy: metabolic implications.
    Karhausen T; Stockburger M; Doehner W; Anker SD
    J Am Coll Cardiol; 2006 Aug; 48(3):591-2; author reply 592. PubMed ID: 16875992
    [No Abstract]   [Full Text] [Related]  

  • 9. [Economic impact of cardiac resynchronization therapy in patients with heart failure. Available evidence and evaluation of the CRT-Eucomed model for analysis of cost-effectiveness].
    Fattore G; Landolina M; Bontempi L; Cacciatore G; Curnis A; Gulizia M; Padeletti L; Mazzei L; Tavazzi L;
    Ital Heart J Suppl; 2005 Dec; 6(12):796-803. PubMed ID: 16444923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of septal to posterior wall motion delay in cardiac resynchronization therapy.
    Pitzalis MV; Iacoviello M; Romito R; Luzzi G; Anaclerio M; Forleo C
    J Am Coll Cardiol; 2006 Aug; 48(3):596-7. PubMed ID: 16876000
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiology patient page. Cardiac resynchronization therapy: a better and longer life for patients with advanced heart failure.
    Iyengar S; Abraham WT
    Circulation; 2005 Sep; 112(13):e236-7. PubMed ID: 16186426
    [No Abstract]   [Full Text] [Related]  

  • 12. Health economics and the European Heart Rhythm Association.
    Vardas P; Boriani G
    Europace; 2011 May; 13 Suppl 2():ii1-2. PubMed ID: 21518741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economical selection of syncope patients for permanent cardiac pacing: a tilted view.
    Grubb BP; Kanjwal K
    Heart; 2013 Jun; 99(11):755-6. PubMed ID: 23503401
    [No Abstract]   [Full Text] [Related]  

  • 14. [How many patients admitted for heart failure are eligible for cardiac resynchronization therapy? Analysis of the Andalusian Heart Failure Registry (RAIC) study].
    García-Pinilla JM; Jiménez-Navarro MF; Anguita-Sánchez M; Martínez-Martínez A; Torres-Calvo F;
    Rev Esp Cardiol; 2007 Jan; 60(1):38-44. PubMed ID: 17288954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-based differences in cardiac resynchronization therapy and implantable cardioverter defibrillator therapies: effectiveness and use.
    Yarnoz MJ; Curtis AB
    Cardiol Rev; 2006; 14(6):292-8. PubMed ID: 17053376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac resynchronization therapy.
    Breithardt OA; Stellbrink C
    Circulation; 2003 Sep; 108(13):e97; author reply e97. PubMed ID: 14517158
    [No Abstract]   [Full Text] [Related]  

  • 17. Pacing in geriatric patients--clinical experience and cost considerations.
    Crowe MJ; Teo KK; Noel GJ; Lavan JN; Browne HI; Horgan JH
    Ir Med J; 1982 Mar; 75(3):87-90. PubMed ID: 6804411
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiac resynchronization therapy and reduction of mortality in heart failure: a proven association].
    Mele D; Toselli T; Pratola C; Artale P; Ferrari R
    G Ital Cardiol (Rome); 2007 Dec; 8(12):760-9. PubMed ID: 18085101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic analysis of a randomized trial of biventricular pacing in Canada.
    Bentkover JD; Dorian P; Thibault B; Gardner M
    Pacing Clin Electrophysiol; 2007 Jan; 30(1):38-43. PubMed ID: 17241313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of end-stage heart failure: does cardiac pacing have anything to offer?
    Chatoor R; Holt P
    Int J Clin Pract; 1999; 53(1):5-7. PubMed ID: 10344058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.